Decision

9 April 2019: Promotion of unlicensed medicines by Apollo Generics Limited

Updated 24 May 2019

The MHRA became aware of a website from Apollo Generics Limited that displayed images of medicines that did not have a UK Marketing Authorisation. Some of the medicines were undergoing licensing assessment.

The MHRA considered that the information on the webpages drew attention to unlicensed products in order to generate sales once they became available. Apollo Generics confirmed that they would update their website to remove reference to unlicensed products.